27 August 2020

All cardiovascular patients can benefit from participation in a cardiac rehabilitation program. People who participate in a program, in which they gain more knowledge about risk factors for cardiovascular disease and receive advice about lifestyle and stress management, live longer on average. This observation was made by Radboud university medical center researchers in collaboration with healthcare insurer VGZ. The results have now been published in JAMA Network Open.
The research shows that only 31% of people who were diagnosed with a new cardiovascular disorder or who underwent heart surgery between 2012 and 2017 participated in a cardiac rehabilitation program. These are people who suffer from chronic heart failure, have had a heart attack, have a stent, and so on. 

No difference in age or gender

Subsequently, the risk of premature death decreased by 32% for this group when compared to patients who did not participate in cardiac rehabilitation. Remarkably, no differences were found in gender, age, socio-economic status, or the presence of any other disorders. Thijs Eijsvogels, exercise physiologist at Radboudumc: “As it turns out, it makes no difference whether someone is over 80 or under 50, and the presence of any other disorders doesn’t matter either. We saw a positive impact on everyone who participated in a cardiac rehabilitation program.”

Stress management and quitting smoking

Cardiac rehabilitation programs take 6–12 weeks on average, and take place at the hospital or a rehabilitation center. The program consists of informative meetings about the risks and effects of a cardiac disorder, healthy food, and the use of medication. Patients also receive active support for quitting smoking, adopting an active lifestyle, etc. Psychological support and dealing with stress may also be included in the program.

Improved information

VGZ researcher Martijn Maessen: “On the basis of anonymized data we have observed that two-thirds of cardiac patients with an indication for cardiac rehabilitation do not participate. There is a lot to be gained now that we know that participation in the program has a positive effect on life expectancy, for example, by improving the information about the health advantages of cardiac rehabilitation.”

Programs stopped during the coronavirus outbreak

In March and April, nearly all cardiac rehabilitation programs were halted to prevent the spread of the coronavirus. Now they are carefully being resumed. Thijs Eijsvogels: “This research shows that cardiac rehabilitation has a positive effect on the life expectancy of people with cardiovascular disorders. It would be good to avoid having to stop the program again if there is a spike in coronavirus cases, because it means that the number of participants decreases. Rehabilitation at home in conjunction with digital and in-person meetings is the way forward.”
Publication in JAMA Network Open
Association of Cardiac Rehabilitation With All-Cause Mortality Among Patients With Cardiovascular Disease in the Netherlands РThijs M.H. Eijsvogels, Martijn F.H. Maessen, Esm̩e A. Bakker, Esther P. Meindersma, Niels van Gorp, Nicole Pijnenburg, Paul D. Thompson, Maria T.E. Hopman.
  • Want to know more about these subjects? Click on the buttons below for more news.

    RIHSVascular damage

Related news items

Grants for science communication at Radboudumc

22 April 2021

Scientists at the Radboudumc have received two KNAW grants, each worth 10,000 euros, for science communication. With the new fund, KNAW underlines importance of making science accessible.

read more

Obesity increases risk of death in uterine cancer PhD defense of Hannah Donkers on 22 April

22 April 2021

Research by Hannah Donkers shows that obesity causes a worse survival rate in women with uterine cancer. In addition, it appears that lower socioeconomic class and anemia also contribute.

read more

Patients who are obese or overweight are at risk for a more severe course of COVID-19

19 April 2021

International study shows risk of mortality does not increase

read more

Vici grant for Michiel Vermeulen Reading the epitranscriptome

15 April 2021

Michiel Vermeulen, theme Cancer development and immune defense, has been awarded a Vici grant from the Netherlands Organisation for Scientific Research (NWO), one of the largest personal scientific awards in the Netherlands.

read more

2.5 million Euros for cancer research into ovarian cancer and immunotherapy

15 April 2021

The Radboudumc receives 2.5 million Euros from the Dutch Cancer Society (KWF) for three studies to ensure oncological progress during COVID-19 period.

read more

Miljoenen voor kennis- en investeringsconsortium op het gebied van AI

14 April 2021

Een kennis- en investeringsconsortium met het Radboudumc heeft acht miljoen euro subsidie gekregen om innovatie op het gebied van Artificial Intelligence (AI) versneld naar de markt te brengen.

read more